Claudio U. Köser
Claudio U. Köser
Verified email at
Cited by
Cited by
Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak
CU Köser*, MTG Holden*, MJ Ellington*, ...
New England Journal of Medicine 366 (24), 2267-2275, 2012
Routine use of microbial whole genome sequencing in diagnostic and public health microbiology
CU Köser, MJ Ellington, EJP Cartwright, SH Gillespie, NM Brown, ...
PLoS Pathogens 8 (8), e1002824, 2012
The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee
MJ Ellington, O Ekelund, FM Aarestrup, R Canton, M Doumith, C Giske, ...
Clinical Microbiology and Infection 23 (1), 2-22, 2017
A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis
P Miotto, B Tessema, E Tagliani, L Chindelevitch, AM Starks, C Emerson, ...
European Respiratory Journal 50 (6), 2017
Whole-genome sequencing to control antimicrobial resistance
CU Köser, MJ Ellington, SJ Peacock
Trends in Genetics 30 (9), 401-407, 2014
Whole-genome sequencing for rapid susceptibility testing of M. tuberculosis
CU Köser, JM Bryant, J Becq, ME Török, MJ Ellington, MA Marti-Renom, ...
New England Journal of Medicine 369 (3), 290-292, 2013
Rapid bacterial whole-genome sequencing to enhance diagnostic and public health microbiology
S Reuter, MJ Ellington, EJP Cartwright, CU Köser, ME Török, T Gouliouris, ...
JAMA Internal Medicine 173 (15), 1397-1404, 2013
Technical report on critical concentrations for drug susceptibility testing of medicines used in the treatment of drug-resistant tuberculosis
World Health Organization
World Health Organization, 2018
Mycobacterium tuberculosis drug-resistance testing: challenges, recent developments and perspectives
T Schön, P Miotto, CU Köser, M Viveiros, E Böttger, E Cambau
Clinical Microbiology and Infection 23 (3), 154-160, 2017
Genomic diversity among drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis with identical DNA fingerprints
S Niemann*, CU Köser* (*equal contributions), S Gagneux, C Plinke, ...
PLoS One 4 (10), e7407, 2009
A pilot study of rapid whole-genome sequencing for the investigation of a Legionella outbreak
S Reuter, TG Harrison, CU Köser, MJ Ellington, GP Smith, J Parkhill, ...
BMJ Open 3 (1), e002175, 2013
What Is resistance? Impact of phenotypic versus molecular drug resistance testing on therapy for multi- and extensively drug-resistant tuberculosis
J Heyckendorf, S Andres, CU Köser, ID Olaru, T Schön, E Sturegård, ...
Antimicrobial Agents and Chemotherapy 62 (2), e01550-17, 2018
Genome sequencing defines phylogeny and spread of methicillin-resistant Staphylococcus aureus in a high transmission setting
SYC Tong, MTG Holden, EK Nickerson, BS Cooper, CU Köser, A Cori, ...
Genome Research 25 (1), 111-118, 2015
Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid …
S Kadura, N King, M Nakhoul, H Zhu, G Theron, CU Köser, M Farhat
Journal of Antimicrobial Chemotherapy 75 (8), 2031-2043, 2020
Mycobacterium tuberculosis resistance prediction and lineage classification from genome sequencing: comparison of automated analysis tools.
V Schleusener, CU Köser, P Beckert, S Niemann, S Feuerriegel
Scientific Reports 7, 46327, 2017
Phylogenetic polymorphisms in antibiotic resistance genes of the Mycobacterium tuberculosis complex
S Feuerriegel, CU Köser, S Niemann
Journal of Antimicrobial Chemotherapy 69 (5), 1205-1210, 2014
Rapid whole-genome sequencing for investigation of a suspected tuberculosis outbreak
ME Török, S Reuter, J Bryant, CU Köser, SV Stinchcombe, B Nazareth, ...
Journal of Clinical Microbiology 51 (2), 611-614, 2013
Importance of the genetic diversity within the Mycobacterium tuberculosis complex for the development of novel antibiotics and diagnostic tests of drug resistance
CU Köser, S Feuerriegel, DK Summers, JAC Archer, S Niemann
Antimicrobial Agents and Chemotherapy 56 (12), 6080-6087, 2012
Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data
AS Dean, M Zignol, AM Cabibbe, D Falzon, P Glaziou, DM Cirillo, ...
PLOS Medicine 17 (1), e1003008, 2020
Impact of fgd1 and ddn diversity in Mycobacterium tuberculosis complex on in vitro susceptibility to PA-824
S Feuerriegel*, CU Köser* (*equal contributions), D Baù, S Rüsch-Gerdes, ...
Antimicrobial Agents and Chemotherapy 55 (12), 5718-5722, 2011
The system can't perform the operation now. Try again later.
Articles 1–20